Xiangxue Pharmaceutical (300147) — Capital Reinvestment Ratio
Latest as of September 2025:
0.08x
Xiangxue Pharmaceutical (300147) has a Capital Reinvestment Ratio of 0.08x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥75.64 Million) in capital expenditures (CN¥5.74 Million). See Xiangxue Pharmaceutical (300147) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.08x
Capex / Operating Cash Flow
Operating Cash Flow
CN¥75.64 Million
CNY
Capital Expenditures
CN¥5.74 Million
CNY
Data as of
Sep 2025
Most recent filing
Xiangxue Pharmaceutical Capital Reinvestment Ratio (2007–2025)
This chart tracks Xiangxue Pharmaceutical's Capital Reinvestment Ratio across 19 annual periods.
Annual Capital Reinvestment Ratio for Xiangxue Pharmaceutical (2007–2025)
Year-by-year Capital Reinvestment Ratio for Xiangxue Pharmaceutical from 2007 to 2025. For live market cap and broader valuation context, see 300147 company net worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.15x | CN¥139.63 Million | CN¥21.51 Million | ▼ -92.1% |
| 2024 | 1.94x | CN¥18.17 Million | CN¥35.24 Million | ▲ +811.6% |
| 2023 | 0.21x | CN¥263.44 Million | CN¥56.03 Million | ▼ -86.8% |
| 2022 | 1.62x | CN¥227.38 Million | CN¥367.27 Million | ▼ -26.1% |
| 2021 | 2.18x | CN¥257.56 Million | CN¥562.74 Million | ▼ -20.6% |
| 2020 | 2.75x | CN¥257.18 Million | CN¥707.42 Million | ▼ -65.5% |
| 2019 | 7.96x | CN¥83.02 Million | CN¥661.09 Million | ▲ +46.6% |
| 2018 | 5.43x | CN¥91.24 Million | CN¥495.46 Million | ▼ -23.5% |
| 2017 | 7.10x | CN¥109.53 Million | CN¥777.87 Million | ▼ -28.3% |
| 2016 | 9.91x | CN¥198.48 Million | CN¥1.97 Billion | ▲ +471.9% |
| 2015 | 1.73x | CN¥159.89 Million | CN¥276.95 Million | ▲ +17.6% |
| 2014 | 1.47x | CN¥165.58 Million | CN¥243.85 Million | ▲ +51.8% |
| 2013 | 0.97x | CN¥328.37 Million | CN¥318.55 Million | ▼ -72.4% |
| 2012 | 3.52x | CN¥118.91 Million | CN¥418.12 Million | ▼ -55.0% |
| 2011 | 7.81x | CN¥29.55 Million | CN¥230.69 Million | ▲ +524.1% |
| 2010 | 1.25x | CN¥45.47 Million | CN¥56.87 Million | ▲ +9.3% |
| 2009 | 1.14x | CN¥46.19 Million | CN¥52.86 Million | ▼ -53.7% |
| 2008 | 2.47x | CN¥55.72 Million | CN¥137.71 Million | ▲ +135.7% |
| 2007 | 1.05x | CN¥138.02 Million | CN¥144.73 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow